From developing new therapies that treat and prevent disease to helping people in need, we’re committed to improving health and well-being around the world.
To make a difference in the lives of people globally through our innovative medicines, vaccines, biologic therapies, consumer care and animal health products. We aspire to be the best healthcare company in the world and are dedicated to providing leading innovations and solutions for tomorrow.
To discover, develop and provide innovative products and services
that save and improve lives around
Good health is vital to all of us, and finding sustainable solutions to the most pressing health care challenges of our world cannot wait. That’s why we at Pfizer are committed to applying science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe, effective and affordable medicines and related health care services to the people who need them.
We have a leading portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and we have an industry-leading pipeline of promising new products that have the potential to challenge some of the most feared diseases of our time, like Alzheimer’s disease and cancer.
To ensure we can continue to deliver on our commitments to the patients, customers and shareholders who rely on us, we are focused on improving the way we do business; on operating with transparency in everything we do; and on listening to the views of all of the people involved in health care decisions. Through working in partnership with everyone from patients to health care providers and managed care organizations to world governments and non-governmental organizations, our goal is to ensure that people everywhere have access to innovative treatments and quality health care.
“When my father, Dr. Gabriele Braglia, founded Helsinn in 1976, he had a simple pharmaceutical licensing business in mind. Almost 40 years later, over 500 committed employees and more than 65 commercial and marketing partners are helping us create a large portfolio of cancer-care therapies.
As we move forward, forging new partnerships, developing more innovative cancer-care solutions, and connecting directly with the cancer-care community, we will never forget our fundamental objective: to build better todays for every person affected by cancer”.
Managing Director and CEO
Helsinn Holding SA
Lugano, December 2013
Part of the Johnson Matthey group of companies, Alfa Aesar is a leading manufacturer and supplier of research chemicals, metals and materials in a wide span of applications. For more than 50 years, scientists have relied on Alfa Aesar to supply high purity raw materials for a variety of research and development applications. Today we offer over 45,000 products in stock, in sizes from gram-scale catalog items to semi-bulk and bulk production quantities. With custom manufacturing capabilities to supply many more specialized items, we are a one-stop source for research chemicals, metals and materials.
TCI is a chemical manufacturer that has supplied high-quality organic reagents for over half a century under the motto of: “Contributing to Society through Reagents”.
TCI’s products are used worldwide in a diverse range of research applications, making a difference in people’s lives. This, we believe, is our social contribution.
We are working continually to expand our product lineup, to deliver our products as quickly as possible to our customers around the world, and to make as great a contribution as we can to the progress of our customer’s research.
Sigma-Aldrich is a leading Life Science and High Technology company whose biochemical, organic chemical products, kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical, diagnostics and high technology manufacturing. Sigma-Aldrich customers include more than 1.3 million scientists and technologists in life science companies, university and government institutions, hospitals and industry. The Company operates in 35 countries and has nearly 9,000 employees whose objective is to provide excellent service worldwide. Sigma-Aldrich is committed to accelerating customer success through innovation and leadership in Life Science and High Technology. For more information about Sigma-Aldrich, please visit its website at www.sigma-aldrich.com